Surface contamination with hazardous drugs (HDs) is an ongoing concern that has been addressed by organizations in the form of published standards and best practice guidelines, some of which are under revision and are not currently enforceable. In this activity, the faculty reviews the status of these documents, as well as applicable recommendations from international guidelines. The action plan for routine monitoring of surfaces for HD contamination and post-spill analysis implemented by one health system for use in its affiliated cancer institutes located in urban and rural communities is also described.

Agenda

Welcome and Introduction
Patricia C. Kienle, M.P.A., BCSCP, FASHP

Where Are We Now? Reflections on Domestic and International Guidelines for Monitoring Hazardous Drug Contamination 
Patricia C. Kienle, M.P.A., BCSCP, FASHP

Telling Our Story: Practical Approaches to Monitoring Surfaces for Hazardous Drug Contamination 
Andre D. Harvin, Pharm.D., M.S., and Clinton L. Meachum, CPhT, CSPT

Faculty Discussion and Q&A: Breaking Down Barriers to Put Strategies into Practice 
All faculty

Learning Objectives

  • Summarize the status of USP Chapter <800> and other guidelines and consensus recommendations pertaining to the safe handling and monitoring of hazardous drugs (HDs) in the drug-use process. 
  • Apply strategies for implementing safe handling recommendations and HD monitoring.
  • List surfaces that should be monitored for HD contamination.
  • Develop an action plan for routine monitoring of surfaces for HD contamination and post-spill analysis based on the surface monitoring results.
Faculty

Patricia C. Kienle, M.P.A., BCSCP, FASHP, Activity Chair
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

Andre D. Harvin, Pharm.D., M.S.
Director of Pharmacy, Oncology
Cone Health
Greensboro, North Carolina

Clinton L. Meachum, CPhT, CSPT
Compounding Regulatory Coordinator
Cone Health
Greensboro, North Carolina

Target Audience

This activity was planned to meet the educational needs of pharmacists and pharmacy technicians involved with handling hazardous drugs in clinics, infusion centers, hospitals, and health systems of any size.

Format 
This activity features slide presentations, active learning, and questions/discussion with faculty. 

Format

This online activity consists of slide presentations with pre/posttest assessment, active learning, and evaluation. View the system requirements.

Relevant Financial Relationship Disclosure

The following person in control of this activity’s content has a relevant financial relationship:

Patricia Kienle - BD: Stock Owner

All other persons in control of content do not have any relevant financial relationships with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant relationships have been mitigated prior to the CE activity.

CPE Information

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE #: 0204-0000-21-433-H07-P/T
Release Date: 01/20/2022
Expiration Date: 07/31/2024
Activity Type: Application-based
CE Credits: 1.5 contact hours (0.15 CEUs)
Activity Fee: Free of charge

Process CE Within 60 Days

Participants should claim CE credit for this home-study activity only if they have not claimed credit for the live activity.

To receive CE credit, complete the steps below within 60 days of completing the activity.

  1. View entire presentation and answer all polling questions.
  2. Click "Complete Activity" on the last slide to link to complete the assessment and evaluation.
  3. Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.

After the 60-day deadline, ASHP will no longer be able to report credit(s).